In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line

Abstract

CD133 is 1 of the markers for CSCs in human laryngeal tumors of the Hep-2 cell line. Work on the characterization of these cells provides a powerful tool to investigate the tumorigenic process in the larynx and to develop therapies targeting the CSC.